General Information
KOWA NASH 201
A Phase 2, Multicenter, Placebi-Controlled, Randomized, Double-Blind, 48-Week Study to evaluate the efficacy and Safety of Combination Therapy of K-844-ER and CSG452 in Patients with Npnoncirrhotic Nonalcoholic Steatohepatitis (NASH) With Liver Fibrosis.
| Protocol | K-001-201 |
|---|---|
| Identifier | |
| UID | ee256bf3-4b1f-44c8-9694-5f83d765321d |
| Status | PI Declined |
| Phase | 2 |
| Category | NASH / Adult |
| Launch Year | 0 |
| NCT Number | - |
| Created | 2022-01-11 10:13 |
| Last Updated | 2022-02-25 19:13 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2022-01-11 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Mohseni, Rizwana | RMohseni | No |
| Recruiter | - | No | |
| Coordinator | - | No | |
| Regulatory | Ramirez, Claudia | CRamirez | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Kowa Research Institute, Inc. |
|---|---|
| Division | Kowa Research Institute |
| Team | Kowa Research Institute |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Gray |
| Currency | - |
